Lek Pharmaceuticals dd, a subsidiary of Novartis AG, is a company headquartered in Ljubljana, Slovenia, that develops, manufactures and markets drugs and pharmaceutical products. Robert Ljoljo is the CEO, in this role since 2019. On November 21, 2002 Novartis AG acquired Lek Pharmaceuticals dd for $689.24 million.

Changsha Baishun Biotechnology Co., Ltd., established on 2014-11-13, Business scope includes biotechnology development services,consult,communication service,transfer service;Chemical product research and development;Class I medical device,Class II medical device,Pre-packaged food,Healthy food,sales of cosmetics;Research and development of biological products;drug development;Food Science and Technology Research Services;Medical Equipment Repair;Medical equipment rental service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guilin Haoxin Technology Service Co., Ltd., established on 2014-04-21, Business scope includes scientific and technological information consulting services;Technology project agency service;Technical Market Management Services;Technical support services for technology enterprises;High-tech entrepreneurship services;Intellectual Property Consulting Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Shantou Special Economic Zone Yunbin Pharmaceutical Factory, established on 1990-04-28, Business scope includes pharmaceutical production,Research and development of medical technology,Technical Consulting and Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Daewoong Pharmaceutical Co., Ltd (Korean: 대웅제약) is a Seoul, South Korea-based bioengineering company operating as a subsidiary of Daewoong Co., Ltd., a global health care group. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products in South Korea, including prescription and over-the-counter healthcare products.

Hangzhou Pushai Pharmaceutical Technology Co., Ltd., established on 2012-10-29, Business scope includes technology development,Technical Services,technical consulting:medical products.

Merck Sharp & Dohme LLC, part of Merck & Co., Inc., is a company headquartered in Kenilworth, NJ, that operates as a pharmaceutical company.

Mankind Pharma aspires to aid the community in a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. Mankind Pharma came into existence in 1986, and in 1991, the company was formed into a legal corporation. However, it actively started working as a fully-integrated pharmaceutical company in 1995. Today, Mankind has an employee base of over 14,000 and is racing towards $1 Billion. The company takes great pride in the success of its products ranging from Pharma, OTC, and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Adiction, Gas-O-Fast, Kaloree 1 and many others.

Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids. The company was founded by Dilip Shantilal Shanghvi in 1983 and is headquartered in Mumbai, India.

Lunanbeite Pharmaceutical Co., Ltd., established on 2003-12-16, Business scope includes production,Sales:Western medicine,Chemical raw materials and preparations,Psychotropic drugs,Pharmaceutical Intermediates,Health products,food,medical instruments,cosmetic(Limited to production in industrial parks);drug research and development;Domestic Trade;Import and export of goods and technology;Sales of chemical products(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hangzhou Solipharma Co., Ltd. is a company headquartered in China. The firm operates as a pharmaceutical company.

Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

Hunan Demei Information Technology Co., Ltd., established on 2016-06-01, Business scope includes information technology consulting services;computer technology development,Technical Services;Commodity Information Consulting Service;Information Electronic Technology Services;Science and Technology Information Consulting Services;medical information,Technical Advisory Services;Agricultural projects and technology consulting services;Software technology transfer;Software technical service;Environmental Technology Consulting Services;Intelligent technology transfer;Intelligent technical service;electronic technology transfer;Electronic Technology Services;High-tech entrepreneurship services;Agricultural project planning and design;Materials Science Research,technology development;Technology intermediary service;Technology project bidding service;Technical Market Management Services;Mechanical technology promotion service;Biological control technology promotion service;Medical device technology promotion service;Conference and Exhibition Services;Agricultural Technology Development Services,consult,communication service,transfer service;network technology,intelligent technology,Communication Technology,Research and Development of Communication Technology;Energy-saving technical consultation,communication service,transfer service;Environmental Technology Development Services,consult,communication service,transfer service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Glenmark Generics Ltd., part of Glenmark Pharmaceuticals Ltd., is a company headquartered in Mumbai, India. The firm manufactures and markets generic drugs.

Shanghai Xuanchuang Biotechnology Co., Ltd., established on 2013-12-16, The scope of business includes engaging in biological,chemical technology,Product Testing Technology,Technology development in the field of machine technology,technology transfer,technical consulting,Technical Services,Chemical raw materials(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Analytical testing instrument,Sales of machinery and equipment. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Part of Zhuzhou Qianjin Pharmaceutical Co., Ltd., Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd. is a company headquartered in Zhuzhou, China, that operates pharmacy chains. On October 28, 2004 Hunan Qianjin Pharmacy Retail Chain Holding Co. Ltd. acquired Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd. from Zhuzhou Qianjin Pharmaceutical Co., Ltd. for $1.09 million.

Concert Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with the potential for efficacy and safety, while greatly reducing R&D risk, time, and expense.